Stifel Financial Corp Harrow Health, Inc. Transaction History
Stifel Financial Corp
- $85.8 Billion
- Q1 2024
A detailed history of Stifel Financial Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 520,790 shares of HROW stock, worth $9.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
520,790
Previous 431,973
20.56%
Holding current value
$9.35 Million
Previous $4.84 Million
42.41%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HROW
# of Institutions
123Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$70.4 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$54.1 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$39.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$32.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$17.1 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $486M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...